Short answer:
If you’re looking for an alternative to acyclovir, the most common options are:
| Drug | What it treats (similar to acyclovir) | Why it’s used as a “substitute” |
|------|----------------------------------------|---------------------------------|
| Valacyclovir | Oral HSV (cold sores, genital herpes) and VZV (shingles) | A pro‑drug that’s absorbed better, so you can take it less often (usually 2–3 × daily). |
| Famciclovir | Oral HSV and VZV | Similar spectrum; dosing is 2–3 × daily, slightly different side‑effect profile. |
| Penciclovir 1 % cream | Topical for HSV lesions | For mild, superficial lesions; not an oral substitute but useful if oral meds aren’t suitable. |
| Ganciclovir (oral or IV) | HSV, VZV, CMV (especially in immunocompromised patients) | More potent but also more toxic; used when resistance or severe disease is present. |
| Foscarnet or Cidofovir | CMV, HSV, VZV (especially drug‑resistant strains) | Reserved for severe or resistant cases; IV only. |
---
When to consider a substitute
| Situation | Preferred alternative | Rationale |
|-----------|----------------------|-----------|
| Need a more convenient dosing schedule | Valacyclovir | 1 g twice daily (or 500 mg three times daily) gives plasma levels similar to 5 × daily acyclovir. |
| Patient has gastrointestinal intolerance to acyclovir | Famciclovir | Has a better GI tolerability profile for some patients. |
| Patient can’t tolerate oral medication (e.g., vomiting, dysphagia) | Topical penciclovir | Applied directly to lesions; minimal systemic absorption. |
| Immunocompromised patient or severe disease | Ganciclovir (oral or IV) | Higher potency and broader activity; IV route if the patient can’t take oral meds. |
| Resistant HSV/VZV infection | Foscarnet or Cidofovir | Bypass the viral thymidine kinase pathway that acyclovir relies on. |
---
Typical dosing (for healthy adults)
| Drug | Typical dose for oral HSV (cold sores, genital) | Typical dose for oral VZV (shingles) |
|------|-----------------------------------------------|------------------------------------|
| Valacyclovir | 500 mg 2–3 × daily for 7 days (acute) | 1 g 2–3 × daily for 7–10 days |
| Famciclovir | 250 mg 2–3 × daily for 7 days | 250 mg 2–3 × daily for 7–10 days |
| Ganciclovir | 5 mg/kg IV every 12 h (or oral 125 mg 5 × daily for CMV) | IV for severe VZV in immunocompromised |
| Foscarnet | 90 mg/kg IV every 12 h | IV for resistant VZV/CMV |
| Cidofovir | 5 mg/kg IV weekly (with probenecid) | IV for resistant CMV |
(Always check the most recent guidelines and adjust for renal function, pregnancy, or other comorbidities.)
---
Key points to keep in mind
| Consideration | What to watch for |
|---------------|------------------|
| Renal function | Acyclovir, valacyclovir, and famciclovir are renally cleared. Dose adjustment is required in CKD. Ganciclovir, foscarnet, and cidofovir carry higher nephrotoxicity risks. |
| Side‑effects | Acyclovir: GI upset, rash, rarely neurotoxicity. Valacyclovir: similar but generally better GI tolerability. Famciclovir: GI upset, headache. Ganciclovir: neutropenia, anemia, rash. Foscarnet/Cidofovir: nephrotoxicity, electrolyte disturbances. |
| Drug interactions | Acyclovir/valacyclovir/famciclovir can reduce the efficacy of other drugs (e.g., increased oral levothyroxine absorption). Ganciclovir may potentiate nephrotoxicity of other drugs. |
| Pregnancy & breastfeeding | Acyclovir is category B. Valacyclovir and famciclovir have limited data but are generally considered acceptable. Ganciclovir is category C; foscarnet/cidofovir are category D or X. Discuss with a provider. |
| Resistant infections | If HSV or VZV becomes resistant (e.g., due to chronic use), switch to a drug that bypasses the viral thymidine kinase, such as foscarnet, ganciclovir, or cidofovir. |
| Topical therapy | For mild, localized lesions, penciclovir cream (1 %) or docosanol can be used. They don’t replace systemic therapy for disseminated disease. |
---
Practical steps
1. Confirm the diagnosis – Make sure you’re treating HSV, VZV, or another virus that responds to these agents.
2. Check renal function – Get a serum creatinine/creatinine clearance (CrCl).
3. Choose the drug
* For a quick, easy regimen: Valacyclovir 500 mg twice daily.
* If GI side‑effects are a problem: Famciclovir 250 mg 2–3 × daily.
* If the patient can’t take oral meds: Penciclovir cream or consider IV therapy.
* For immunocompromised or severe disease: Ganciclovir IV (or oral if indicated).
4. Adjust dose for CrCl – Each drug has a clear table for dose adjustments.
5. Monitor for side‑effects – Watch for rash, GI upset, neutropenia (with ganciclovir), or nephrotoxicity (with foscarnet/cidofovir).
6. Follow up – Ensure the infection resolves; if not, reassess for resistance or consider a switch.
---
Bottom line
- Valacyclovir and Famciclovir are the most common, patient‑friendly substitutes for acyclovir for most oral HSV/VZV infections.
- Penciclovir cream is a topical option for mild lesions.
- Ganciclovir, foscarnet, and cidofovir are reserved for severe, disseminated, or drug‑resistant infections and usually require IV administration.
- Always adjust for renal function and review potential drug interactions.
If you’re treating a specific patient, let me know more details (age, kidney function, pregnancy status, whether the infection is localized or disseminated) and I can give a more tailored recommendation.